ATE252384T1 - Trinkbares arzneimittel - Google Patents

Trinkbares arzneimittel

Info

Publication number
ATE252384T1
ATE252384T1 AT98963579T AT98963579T ATE252384T1 AT E252384 T1 ATE252384 T1 AT E252384T1 AT 98963579 T AT98963579 T AT 98963579T AT 98963579 T AT98963579 T AT 98963579T AT E252384 T1 ATE252384 T1 AT E252384T1
Authority
AT
Austria
Prior art keywords
drinkable
medicinal product
medicinal
product
drinkable medicinal
Prior art date
Application number
AT98963579T
Other languages
English (en)
Inventor
Claude Aleman
Philippe Bastard
Marielle Bonnel
Thierry Breul
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of ATE252384T1 publication Critical patent/ATE252384T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
AT98963579T 1997-12-24 1998-12-14 Trinkbares arzneimittel ATE252384T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9716529A FR2772614B1 (fr) 1997-12-24 1997-12-24 Solution aqueuse a base de chlorhydrate de 1- [ 2-(2-naphtyl)ethyl]-4- (3-trifluoromethylphenyl) -1,2,3,6-tetrahydropyridine et composition pharmaceutique buvable en contenant
PCT/FR1998/002712 WO1999033466A1 (fr) 1997-12-24 1998-12-14 Composition pharmaceutique buvable

Publications (1)

Publication Number Publication Date
ATE252384T1 true ATE252384T1 (de) 2003-11-15

Family

ID=9515152

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98963579T ATE252384T1 (de) 1997-12-24 1998-12-14 Trinkbares arzneimittel

Country Status (25)

Country Link
US (1) US6191137B1 (de)
EP (1) EP1041984B1 (de)
JP (1) JP2002510599A (de)
AR (1) AR017722A1 (de)
AT (1) ATE252384T1 (de)
AU (1) AU1880599A (de)
BR (1) BR9814414A (de)
CA (1) CA2315696C (de)
CO (1) CO4970813A1 (de)
DE (1) DE69819203T2 (de)
DK (1) DK1041984T3 (de)
DZ (1) DZ2676A1 (de)
ES (1) ES2209238T3 (de)
FR (1) FR2772614B1 (de)
GT (1) GT199800204A (de)
HU (1) HUP0101012A3 (de)
MY (1) MY117156A (de)
NO (1) NO20003284L (de)
PT (1) PT1041984E (de)
SA (2) SA99191002B1 (de)
SI (1) SI1041984T1 (de)
TW (1) TW536409B (de)
UY (1) UY25320A1 (de)
WO (1) WO1999033466A1 (de)
ZA (1) ZA9811824B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070053883A1 (en) * 2003-03-25 2007-03-08 The Johns Hopkins University Neuronal cell lineages and methods of production thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2702656B1 (fr) * 1993-03-18 1995-06-16 Sanofi Elf Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments cardioprotecteurs.

Also Published As

Publication number Publication date
DE69819203T2 (de) 2004-07-15
CO4970813A1 (es) 2000-11-07
UY25320A1 (es) 2000-10-31
DZ2676A1 (fr) 2004-09-19
FR2772614A1 (fr) 1999-06-25
CA2315696A1 (en) 1999-07-08
AU1880599A (en) 1999-07-19
HUP0101012A2 (hu) 2001-08-28
NO20003284L (no) 2000-08-24
SA99191002B1 (ar) 2006-03-07
ES2209238T3 (es) 2004-06-16
WO1999033466A1 (fr) 1999-07-08
PT1041984E (pt) 2004-02-27
JP2002510599A (ja) 2002-04-09
DK1041984T3 (da) 2004-02-16
DE69819203D1 (de) 2003-11-27
ZA9811824B (en) 1999-06-29
TW536409B (en) 2003-06-11
AR017722A1 (es) 2001-09-12
CA2315696C (en) 2008-01-29
BR9814414A (pt) 2000-10-10
MY117156A (en) 2004-05-31
EP1041984B1 (de) 2003-10-22
FR2772614B1 (fr) 2000-03-10
GT199800204A (es) 2000-06-14
US6191137B1 (en) 2001-02-20
SA99191003B1 (ar) 2006-10-02
NO20003284D0 (no) 2000-06-22
EP1041984A1 (de) 2000-10-11
HUP0101012A3 (en) 2002-12-28
SI1041984T1 (en) 2004-04-30

Similar Documents

Publication Publication Date Title
ATE248594T1 (de) Irbesartanhaltiges arzneimittel
ATE240732T1 (de) Ziprasidonhaltige arzneimittel
DE69900162T2 (de) Arzneimittel enthaltend Oxaliplatin
DE122010000011I1 (de) Flüssige gonadotropinhaltige Arzneimittel
DE69513671D1 (de) Arzneimittel
FI954402A (fi) Uusi farmaseuttinen tuote
FI970038A0 (fi) Kosteuttava valmiste
DE69840622D1 (de) Kosmetikprodukt
ATE367150T1 (de) Arzneimittel
PT862863E (pt) Produto cerealifero contendo probioticos
FI932655A (fi) Imidatderivat av farmaceutiskt anvaendbara antikonvulsiva sulfamat
ATE284951T1 (de) Futtermittelprodukt
DE19581419T1 (de) Würzmittel-Abgabevorrichtung
ATE237320T1 (de) Venlafaxinhaltiges arzneimittel mit verlängerter wirkstoffabgabe
GB9726563D0 (en) Novel pharmaceutical
GB9801538D0 (en) Pharmaceutical product
EG23694A (en) Novel pharmaceutical
DE69709349T2 (de) Arzneimittel bestehend aus diclofenac
ATE269337T1 (de) Trizyclische delta3-pyridine als arzneimittel
BR9711981A (pt) Produto farmac-utico cristalino
DE60008237D1 (de) Lamivudin enthaltende arzneimittel
DK108397A (da) Konfektureprodukt
ATE252384T1 (de) Trinkbares arzneimittel
DE59805373D1 (de) Nephroprotektive Arzneimittel
GB9706376D0 (en) Novel pharmaceutical

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1041984

Country of ref document: EP

REN Ceased due to non-payment of the annual fee